390 likes | 749 Views
Overview . Intro to SNHPA and NRHABackground on 340B programExpansion to new rural hospitalsEnrollment processGPO exclusion Orphan drugsStrategies to maximize 340B program benefitsKey program challenges340B legislationSNHPA advocacy goals/membershipUpcoming events/Q
E N D
1. 340B for Newly Eligible Rural Hospitals
Safety Net Hospitals for Pharmaceutical Access
National Rural Health Association
July 7, 2010, 1:00 p.m. to 2:30 p.m. EDT
Toll free: 1-866-237-3252
Participant Passcode: 308407
William von Oehsen Anna Mangum
SNHPA President/General Counsel SNHPA Director - Programs & Membership
Brock Slabach Maggie Elehwany
NRHA Sr. Vice-President for NRHA Vice President, Government Affairs
Member Services and Policy
`
2. Overview Intro to SNHPA and NRHA
Background on 340B program
Expansion to new rural hospitals
Enrollment process
GPO exclusion
Orphan drugs
Strategies to maximize 340B program benefits
Key program challenges
340B legislation
SNHPA advocacy goals/membership
Upcoming events/Q&A
3. Who is SNHPA? Non-profit organization representing and supporting 500+ hospitals and health systems in 340B – including rural hospitals
Board Chair is CEO of network of rural hospitals
Took lead role in including hospitals in the 340B law – including rural hospitals
Advocates on federal legislative and regulatory issues related to drug pricing and other pharmacy matters affecting safety-net providers
Educates members on 340B policy developments in Congress and regulatory agencies
4. Who is NRHA? National nonprofit membership organization with more than 20,000 members (individuals and organizations)
Mission: To provide leadership on rural health issues
Nine (9) recognized constituency groups:
Community Health Status
Clinical Services
Community-operated Practices
Frontier
Hospitals and Community Health Systems
Diverse Underserved Populations
Research and Education
Rural Health Clinics
Statewide Health Resources
5. Background on 340B Program Created by Congress in 1992 to lower the drug costs of safety net providers
Legislative intent: to help safety net providers stretch their scarce tax dollars in order to provide more services and serve more vulnerable patients
Administered by Office of Pharmacy Affairs (OPA) within the Health Resources and Services Administration (HRSA)
Requires drug manufacturers participating in Medicaid and/or Medicare Part B to sell “covered outpatient drugs” to “covered entities” at discounted prices determined by statutory formulas.
5
6. Background (cont’d) Discounts based on Medicaid rebate formulas
Greater discounts for brand name drugs, lesser discounts for generics
Prices are best in nation outside of “Big Four”
25-50% off group purchasing organization (GPO) contracts
Applies to both pharmacy-dispensed and clinic-administered drugs
Do not need to own and operate an outpatient pharmacy to participate 6
7. 340B Price Comparisons
8. 340B Covered Entities Prior to Health Reform High-Medicaid disproportionate share hospitals (DSHs)
Free-standing children’s hospitals
Community health centers
AIDS drug assistance programs (ADAPs)
Black lung clinics
Ryan White AIDS clinics Federally qualified health center “look alikes”
Hemophilia treatment centers
Native Hawaiian health centers
Urban Indian clinics/638 tribal centers
Title X family planning clinics
STD clinics
TB clinics 8 The Consolidated Health Center program includes community health centers, migrant health centers, health care for the homeless, public housing primary care and school-based health centers. The Consolidated Health Center program includes community health centers, migrant health centers, health care for the homeless, public housing primary care and school-based health centers.
9. Background (cont’d) OPA maintains databases of participating covered entity sites, manufacturers, & contract pharmacies
Registered as of June 29, 2010:
14,600 covered entities
870 manufacturers
3900 pharmacies
Over 800 hospitals currently enrolled
Some rural hospitals already participating
Examples include sole community hospitals and rural referral centers with DSH adjustment percentages above 11.75%
9
10. Background (cont’d) OPA relies extensively on support from two HRSA contractors: Prime Vendor Program (PVP) and Pharmacy Support Services Center (PSSC)
PVP contractor: Apexus
Negotiates sub-ceiling pricing on behalf of PVP participants
Provides other value-added services
No cost to join
PSSC contractor: American Pharmacists Association
Provides technical assistance to covered entities and other stakeholders
Staffs 340B call center
No charge for services
10
11. Health Reform and 340B 340B provisions in health reform are first changes to program since its inception in1992
Impacts all 340B stakeholders -- particularly rural hospitals
SNHPA, NRHA and other hospital groups all pushed for expansion
12. Expansion to New Entities Now eligible:
Free-standing children’s hospitals & free-standing cancer hospitals that have Medicare DSH adjustment > 11.75%
Sole community hospitals and rural referral centers that have Medicare DSH adjustment
= 8%
Critical access hospitals (no DSH threshold)
13. Limits on Participation All eligible hospitals must either be publicly owned or a private nonprofit corporation under contract with state or local government to provide indigent care
For-profit hospitals are not eligible
What is Medicare DSH adjustment?
Medicare add-on payment for hospitals treating disproportionate share of low income patients
Driven by Medicaid and SSI inpatient days
List of hospitals with qualifying DSH adjustments available on OPA website
SNHPA can assist in assessing your hospital’s eligibility
OPA list is sometimes out of date and inaccurate
Appeals process
14. Enrollment for New Entities Enrollment anticipated in 3rd or 4th quarter of 2010
Waiting for additional funding
Enrollment usually starts at beginning of calendar quarter after approved
“Rolling admission” is possible
First step, prior to applying for enrollment:
Determine ownership status
If private, non-profit hospital, look for or establish indigent care agreement with state or local government
SNHPA can help
15. GPO Prohibition Modified for Rural Hospitals Once enrolled, DSH, children’s, and cancer hospitals may not obtain covered outpatient drugs through GPO or other group purchasing arrangement
If using GPO, must discontinue GPO use for outpatient drugs before enrollment
May continue to use GPO for inpatient drugs and med/surg supplies
GPO prohibition does not apply to critical access hospitals or to sole community hospitals or rural referral centers with DSH adjustments of 8%-11.75%
16. Orphan Drug Exclusion “Orphan drugs” excluded from 340B for newly-eligible entities
Almost 350 such drugs, including some high-priced cancer drugs, many used for multiple indications other than indication(s) designated for orphan status
Orphan drugs include Bevacizumab, Remicade, Oncaspar, Elaprase, Neupogen, and most IVIG and factor therapies
For a list, visit www.snhpa.org/public/documents/excel/OrphanDrugList.xls
Exclusion will likely be applied regardless of whether drug is for rare condition or not
17. Orphan Drug Exclusion (cont’d) SNHPA, NRHA, NACHRI challenging exclusion
Children’s hospitals fix in House jobs/tax bill
Awaiting Senate approval, but may need new legislative vehicle
Rural hospitals will not fully benefit until orphan drug exclusion is fixed
SNHPA, NRHA to survey members
Will need your help on Capitol Hill!
18. Maximizing 340B Program Benefits: Strategies Extend 340B to all eligible facilities
Extend 340B to all eligible patients
Purchase all covered outpatient drugs through 340B
Establish contract pharmacy arrangements
19. Extend 340B to All Eligible Facilities Include all components of eligible hospital in 340B program
Any facility whose costs are reimbursable on hospital’s Medicare cost report is considered part of 340B hospital
Typically facilities are “provider-based” under Medicare
Examples:
rural health clinics
oncology clinics
nursing homes and other long-term care facilities
Consider moving non-hospital facilities under 340B hospital to take advantage of 340B pricing
20. Extend 340B to All Eligible Patients Is your hospital using 340B for all eligible patients?
HRSA’s patient definition test:
Relationship with individual patient such that hospital maintains records of individual’s health care; and
The individual receives health care services from health care professional employed by hospital or provides health care under contractual or other arrangement (e.g. referral) such that responsibility for care remains with hospital.
21. Extend 340B to All Eligible Patients (cont’d) Hospital may use 340B for prescriptions written:
In connection with services rendered within a hospital-based facility,
By a prescriber who is treating the patient within the scope of his or her employment or contract with the hospital, or
By a non-hospital prescriber if the services provided are proximate in type and time to prior hospital-based services
22. Long-term care facility residents
Home health patients
Employees
Prisoners
Mental health patients
Managed care enrollees
Extend 340B to All Eligible Patients (cont’d)
23. Purchase All Covered Outpatient Drugs Through 340B Many hospitals do not use 340B drugs in “mixed use” settings due to concerns about diversion
Split-billing software can help
Anesthesia products and other liquid or gas drugs can be bought through 340B if based on reasonable methodology for excluding inpatient
Some manufacturers interpret “covered outpatient drug” narrowly e.g., Integrillin, Thrombin, etc.
24. Contract Pharmacy Opportunities/Challenges Previously: Limit of one contract pharmacy per covered entity; could not have both in-house and contract pharmacy
April 5: Limits removed. Multiple contracts permissible even if hospital has in-house pharmacy
Particularly helpful in increasing patient access to 340B pharmacy services for rural hospitals, especially those lacking outpatient pharmacies
Hospitals may be able to capture higher percentage of outpatient prescription drug business
New compliance challenges, including “expectation of” annual independent audits, required ongoing monitoring of compliance and reporting of noncompliance
25. Contract Pharmacy Opportunities/Challenges (cont’d) Consider contracting with one or more outside pharmacies even if you have an in-house outpatient pharmacy
Less overhead
Options include chain drug stores, independent pharmacies, mail order pharmacies and/or telepharmacy companies
Working with pharmacies in your community will help to ensure support of 340B program by pharmacists who may otherwise view 340B as competition
26. Key Program Challenges Keeping 340B and non-340B inventories separate may require special expertise and resources
Software, technology, vendors available to help
Some Medicaid agencies expect 340B savings to be passed through to the program
However, models exist for sharing 340B savings with the state (SNHPA can help)
HRSA would like to narrow definition of “eligible patient”
SNHPA and other 340B Coalition members have successfully challenged those efforts so far
27. 340B Legislation Victories in health reform
Program expanded to rural hospitals
Tougher enforcement of drug industry to ensure compliance with the law
Improved price verification methods
28. Continued Challenges Expansion of 340B to inpatient setting
Currently 340B inpatient discounts voluntary
Legislation requiring drug industry to offer inpatient discounts signed by President but removed one week later
Pharmaceutical industry offered a modest step towards inpatient program: 340B-1
29. Next Steps on Inpatient 340B-1
Limited inpatient extension in House jobs/tax bill
Only for uninsured patients
DSH hospitals would need adjustments of 20.2% or greater to qualify
Most rural hospitals would be eligible since DSH adjustment requirements would be same as under 340B
30. Next Steps on Inpatient (cont’d) 340B-1
SNHPA has some concerns with legislation
Too limited in scope
Difficult compliance standards and Office of Inspector General (OIG) investigations
Standards in 340B-1 could apply to current outpatient program
31. SNHPA’s Advocacy Goals Extend 340B to inpatient setting without restrictions
Help hospitals utilize current program to fullest extent without compromising program integrity
Address orphan drug restrictions
Protect against patient definition being unduly restricted
Reasonable Medicaid billing requirements
32. SNHPA Membership Benefits Free technical assistance calls with attorneys and other professionals with 18 years of 340B experience
Help with application and implementation questions
Guidance on contract pharmacies
Inventory management guidance
Biweekly electronic bulletin
Free subscription to The Drug Discount Monitor
Best practice tools
“Survival Kit”
33. SNHPA Membership Benefits (cont’d) Comprehensive comparison tools
Pricing clearinghouse
Identify and recover overcharges
Free regional roundtables
State and federal policy tracking tools
Patient assistance programs information
Medicare Part D Resources Center
Members-only listserv
Significant discounts on membership for small hospitals
34. Membership Options Small hospital membership: $975
For hospitals w/25 or fewer beds
Three (3) technical assistance calls
Membership dues range from $1,650 to $7,500 for larger hospitals and those seeking additional technical assistance
Affiliate membership: $500
For hospitals not yet enrolled in 340B
35. SNHPA Rural HospitalAdvisory Committee Open to rural hospital members
Meets every other month via teleconference to provide input into new programs for rural hospitals
Co-chairs (SNHPA Board members):
Dr. Charles Hart, CEO, Rapid City Regional Health, Inc. (SD)
Brad Atherton, Director of Pharmacy, John D. Archbold Memorial Hospital (GA)
To join, contact Anna Mangum at anna.mangum@snhpa.org or (202) 552-5863
36. Upcoming Events
14th Annual 340B Coalition Conference
Co-hosted by Apexus
July 19-21, 2010
Washington, DC
www.340bcoalition.org
*Special breakout sessions for rural providers
SNHPA Legislative Day
July 22, 2010
Contact Jaimie Vickery at (202) 552-5855 or
jaimie.vickery@snhpa.org
37. SNHPA Resources SNHPA
1501 M Street, NW, 7th Floor
Washington, DC 20005
Phone: 202-552-5850
Fax: 202-552-5868www.snhpa.org
SNHPA Newsletter
Drug Discount Monitor
www.drugdiscountmonitor.com
(free for members)
340B Career Resource
www.rxjobsolutions.com
(member discounts)
38. SNHPA Contact Information Bill von Oehsen
President/General Counsel
(202) 872-6765
william.vonoehsen@
snhpa.org
Ted Slafsky
Executive Director
(202) 552-5860
ted.slafsky@snhpa.org
Anna Mangum
Director, Programs and Membership
(202) 552-5863
anna.mangum@snhpa.org
Rob Recklaus
Director of Government Relations
(202) 552-5852
Rob.recklaus@snhpa.org
39. NRHA Contact Information Brock Slabach
Sr. Vice-President for Member Services
(816) 756-3140 ext. 14
bslabach@nrharural.org
Maggie Elehwany
Vice President, Government Affairs and Policy
(202) 639-0550
elehwany@nrharural.org
40. Question & Answer Session To ask a question via your telephone, press *1 to connect to the operator and be put in the queue.
To ask a written question, click on the Q&A button at the top left of your screen.
The presentation is available for download by clicking on the handouts button ( ) at the top right of your screen.